Decreased Risk of Acute Gastrointestinal Toxicity When Substituting Methotrexate With Mycophenolate Mofetil in the Prevention of Graft-Versus-Host Disease in Stem Cell Transplantation Following Myeloablative Conditioning Regimens

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705227
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Mycophenolate Mofetil for the Prevention and Treatment of Graft-Versus-Host Disease Following Stem Cell Transplantation: Preliminary Findings

Bone Marrow Transplantation
TransplantationHematology
2001English

The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease After Stem-Cell Transplantation From Unrelated Donors

American Journal of Hematology
Hematology
2017English

Comparison of Mycophenolate Mofetil (MMF) Versus Methotrexate (MTX) for Prevention of Acute Graft-Versus-Host Disease: Results of a Meta-Analysis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Cyclosporine a and Mycophenolate Mofetil vs Cyclosporine a and Methotrexate for Graft-Versus-Host Disease Prophylaxis After Stem Cell Transplantation From HLA-identical Siblings

Bone Marrow Transplantation
TransplantationHematology
2005English

Folic Acid Supplementation During Methotrexate Immunosuppression Is Not Associated With Early Toxicity, Risk of Acute Graft-Versus-Host Disease or Relapse Following Hematopoietic Transplantation

Bone Marrow Transplantation
TransplantationHematology
2006English

Role of Conditioning Regimens in Pediatric Hematopoietic Stem Cell Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Acute and Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

Revista da Associacao Medica Brasileira
Medicine
2016English

Demodocidosis Accompanying Acute Cutaneous Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation

Turkish Journal of Haematology
Hematology
2018English

A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy